Discuss how recent developments, pending legislation, and the election may affect the cannabis industry. Delve into the impacts of rescheduling and other tax and accounting issues while exploring innovative deals and corporate structures being used to permit investments and licensing deals. Plus, hear the latest trends in hemp.

Speakers:
Eric P. Berlin, JD, Partner, Leader of Cannabis Group | Dentons
Amy Rubenstein, JD, Partner | Dentons

Earlier this year, the U.S. Drug Enforcement Agency announced the potential reclassification of cannabis from Schedule I controlled substance to Schedule III. Hear how this change could have a major impact on the current tax landscape and the focus of cannabis businesses.  

Moderator:
Luis Plascencia, CPA, CPA Practitioner/Principal | Luis V. Plascencia CPA

Panelists:
Marc Claybon, CPA | Crowe, LLP
Jessica Velazquez, CPA | Indiva Advisors

Hear one accounting and finance professional’s experiences while working in the cannabis industry. Explore the lessons learned, challenges encountered, and knowledge gained. 

Speaker:
Rich Tarapchak, CPA, Executive Vice President, Finance & Corporate Controller | Verano Holdings

Explore the current trends in accounting and auditing impacting cannabis operators today. Examine ASC 740 considerations for 280E and potential rescheduling, valuation and impairment, other emerging considerations, and more.  

Moderators:
Nathan Summers, CPA, Principal | Miller Cooper
Neil Prasad, CPA, Partner, Capital Markets and Cannabis Leader – Midwest | Marcum LLP

Panelists:
Jay Joyce, CPA, Senior Manager | Crowe LLP
Kevin Zanni, ASA, CVA, CBA, CFE, Valuation Principal | Miller Cooper & Co., Ltd.